Bank of New York Mellon Corp - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 138 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$6,956,125
+1.0%
311,236
-2.9%
0.00%
+100.0%
Q2 2023$6,884,795
-11.9%
320,372
-1.7%
0.00%
-50.0%
Q1 2023$7,815,847
+3.7%
325,796
+0.2%
0.00%0.0%
Q4 2022$7,539,629
+30.6%
324,984
-9.8%
0.00%
+100.0%
Q3 2022$5,774,000
-10.2%
360,454
-0.6%
0.00%0.0%
Q2 2022$6,427,000
-18.6%
362,643
-6.5%
0.00%
-50.0%
Q1 2022$7,893,000
+6.0%
387,652
-2.7%
0.00%
+100.0%
Q4 2021$7,446,000
+2.3%
398,532
+8.1%
0.00%0.0%
Q3 2021$7,280,000
-15.3%
368,827
+1.5%
0.00%
-50.0%
Q2 2021$8,594,000
-7.4%
363,482
-7.2%
0.00%0.0%
Q1 2021$9,281,000
+139.8%
391,587
+102.6%
0.00%
+100.0%
Q4 2020$3,871,000
+1.3%
193,258
+5.3%
0.00%0.0%
Q3 2020$3,821,000
+16.1%
183,532
-2.4%
0.00%0.0%
Q2 2020$3,292,000
+8.3%
188,105
+1.1%
0.00%0.0%
Q1 2020$3,039,000
-23.6%
186,092
-3.8%
0.00%0.0%
Q4 2019$3,979,000
+79.1%
193,365
-0.1%
0.00%0.0%
Q3 2019$2,222,000
-10.8%
193,561
+2.1%
0.00%0.0%
Q2 2019$2,492,000
-11.1%
189,543
+2.4%
0.00%0.0%
Q1 2019$2,802,000
-13.0%
185,019
-1.4%
0.00%0.0%
Q4 2018$3,222,000
+10.9%
187,647
-4.8%
0.00%0.0%
Q3 2018$2,906,000
-48.8%
197,168
-17.2%
0.00%
-50.0%
Q2 2018$5,678,000
-22.3%
238,025
-16.8%
0.00%0.0%
Q1 2018$7,310,000
+76.5%
286,098
+27.5%
0.00%
+100.0%
Q4 2017$4,142,000
+276.9%
224,372
+114.2%
0.00%
Q3 2017$1,099,000
-16.3%
104,732
-0.2%
0.00%
Q2 2017$1,313,000
+100.2%
104,961
+60.7%
0.00%
Q1 2017$656,000
-31.5%
65,305
+6.1%
0.00%
Q4 2016$958,000
-4.1%
61,530
+18.6%
0.00%
Q3 2016$999,000
-69.1%
51,900
-81.0%
0.00%
-100.0%
Q2 2016$3,235,000
-47.2%
272,981
-19.1%
0.00%
-50.0%
Q1 2016$6,129,000
+729.4%
337,623
+1155.5%
0.00%
Q4 2015$739,000
+24.4%
26,8920.0%0.00%
Q3 2015$594,000
+40.1%
26,892
+13.1%
0.00%
Q2 2015$424,00023,7740.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q4 2020
NameSharesValueWeighting ↓
Rubric Capital Management LP 2,606,500$51,452,0001.44%
Camber Capital Management LP 2,000,000$39,480,0001.22%
Eventide Asset Management 2,629,593$51,908,0000.68%
GREAT POINT PARTNERS LLC 121,342$2,395,0000.56%
RICE HALL JAMES & ASSOCIATES, LLC 753,038$14,865,0000.55%
Values First Advisors, Inc. 41,773$825,0000.53%
CLARK ESTATES INC/NY 183,800$3,628,0000.52%
EMERALD MUTUAL FUND ADVISERS TRUST 710,398$14,023,0000.48%
EMERALD ADVISERS, LLC 590,256$11,652,0000.42%
ACORN FINANCIAL ADVISORY SERVICES INC /ADV 68,812$1,358,0000.42%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders